To confirm that tumor-reactive CD8+ T cells only existed in the brain, we assessed T cells from the brains and draining lymph nodes (dLNs) of naïve mice and T-αFGL2-treated survivors 7 days after the rechallenge with DBT cells. Here, CD8A is linked to neoplasm.